Hydrogels Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Hydrogels Pipeline Market Report Overview

Hydrogels include dressings that consist of more than 90% water with a matrix of insoluble polymers embedded in it. The former helps to maintain a moist wound environment while the latter facilitates absorption of wound exudates. These dressings are available in the form of tubes and sheets. Both are tracked under this segment. Hydrogels are segmented into antimicrobial and non-antimicrobial hydrogel dressings.

The hydrogels pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials.

Key Segment ·       Antimicrobial Hydrogel Dressings

·       Non-Antimicrobial Hydrogel Dressings

Key Territories ·       The United States

·       Europe

·       Australia

·       Israel

·       Canada

Key Regulatory Paths ·       510(k)

·       CE

·       TGA

·       NMPA

·       MDITAC

·       MDL

Leading Companies ·       3QMatrix, Inc. (Inactive)

·       Abeona Therapeutics Inc

·       Alafair Biosciences Inc

·       Albert Ludwigs University of Freiburg

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

 Buy the Full Report for More Insights into the Hydrogels Pipeline Market

Download a Free Report Sample

Hydrogels Pipeline Market Segments

The key segments in the hydrogels pipeline market are Antimicrobial Hydrogel Dressings and Non-Antimicrobial Hydrogel Dressings. Antimicrobial Hydrogel Dressings had the highest number of pipeline products in the hydrogels pipeline market as of July 2024.

Hydrogels Pipeline Market Analysis by Segments, 2024 (%)

Hydrogels Pipeline Market Analysis by Segments, 2024 (%)

Buy the Full Report for More Insights into the Hydrogels Pipeline Market

Download a Free Report Sample

Hydrogels Pipeline Market Segmentation by Territories

The United States (US), Europe, Australia, Israel, and Canada among others are a few of the key territories of the inhaler pipeline market. As of July 2024, the US accounts for the highest number of pipeline products.

Hydrogels Pipeline Market Analysis by Territories, 2024 (%)

Hydrogels Pipeline Market Analysis by Territories, 2024 (%)

Buy the Full Report for More Territory Insights into the Hydrogels Pipeline Market

Download a Free Report Sample

Hydrogels Pipeline Market Segmentation by Regulatory Paths

A few of the key regulatory paths in the hydrogels pipeline products market are 510(k), CE, TGA, NMPA, MDITAC, and MDL. As of July 2024, 510(k) is the most followed pathway for pipeline products in the hydrogels market.

Hydrogels Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Hydrogels Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Buy the Full Report for More Regulatory Path Insights into the Hydrogels Pipeline Market

Download a Free Report Sample

Hydrogels Pipeline Market – Competitive Landscape

A few of the key companies associated with the hydrogels pipeline market are 3QMatrix, Inc. (Inactive), Abeona Therapeutics Inc., Alafair Biosciences Inc., and Albert Ludwigs University of Freiburg, among others.

Abeona Therapeutics Inc: Abeona Therapeutics Inc (Abeona), formerly PlasmaTech Biopharmaceuticals Inc, is a biopharmaceutical company that develops and delivers gene therapy and plasma-based products for severe life-threatening rare diseases. The company’s lead programs include EB-101, ABO-101 and ABO-102 adeno-associated virus.

Albert Ludwigs University of Freiburg (Universitat Freiburg): Albert Ludwigs University of Freiburg (Universitat Freiburg) is an educational institute. The university offers bachelor’s, master, English language courses, English speaking bachelors, English speaking masters, German French courses, continuing education courses, expiring and cancelled courses, and degree courses services among others. Bachelor Services include business administration, political science, and archaeological sciences among others.  It also provides research training for students.

Hydrogels Pipeline Market Analysis by Companies, 2024
Hydrogels Pipeline Market Analysis by Companies, 2024Buy the Full Report for More Company Insights into the Hydrogels Pipeline Market
Download a Free Report Sample

Segments Covered in the Report

Hydrogels Pipeline Market Segments Outlook (2024)

  • Antimicrobial Hydrogel Dressings
  • Non-Antimicrobial Hydrogel Dressings

Hydrogels Pipeline Market Territories Outlook (2024)

  • The United States
  • Europe
  • Australia
  • Israel
  • Canada

Hydrogels Pipeline Market Regulatory Paths Outlook (2024)

  • 510(k)
  • CE
  • TGA
  • NMPA
  • MDITAC
  • MDL

Scope

This report provides:

  • Extensive coverage of the hydrogels under development.
  • Exhaustive list of major pipeline products and their details, including product description, licensing and collaboration details, and other developmental activities.
  • Reviews of major players involved in the development of hydrogels and lists all their pipeline projects.
  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
  • Key clinical trial data of ongoing clinical trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to Buy

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.
  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.
  • Identify and understand important and diverse types of hydrogels under development.
  • Develop market-entry and market-expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
  • Carry out an in-depth analysis of the product’s current stage of development, territory, and estimated launch date.

3QMatrix, Inc. (Inactive)
Abeona Therapeutics Inc
Alafair Biosciences Inc
Albert Ludwigs University of Freiburg
Amend Surgical, Inc.
Angiotech Pharmaceuticals Inc
AXXO Im- und Export GmbH
BioCure Inc
Biomendics LLC
Brigham and Women's Hospital
CelaCare Technologies LLC
Ceramicos Para Aplicacoes Medicas SA
Chi2Gel Ltd.
Clyra Medical Technologies Inc
CorMedix Inc
Drexel University
ECM Therapeutics Inc
Edixomed Ltd
Exogenus Therapeutics SA
Flexion Therapeutics Inc
Gel4Med Inc
Gelesis Inc
GelSana Therapeutics Inc
HyperBranch Medical Technology Inc
Icahn School of Medicine at Mount Sinai
In2cure AB
Indian Institute of Technology Delhi
Indian Institute of Technology, Kanpur
Institute of Nano Science and Technology
Ionic Pharmaceuticals LLC
IPI Singapore
Jenarron Therapeutics Ltd
Johns Hopkins University
Kane Biotech Inc
Keratin Biosciences Inc
Magle Chemoswed AB
McMaster University
Missouri University of Science and Technology
Neotherix Ltd
Northwestern University
Novyx Technologies LLC
O2 Regentech LLC
Ohio State University
Orla Protein Technologies Ltd
Piramal Enterprises Ltd
Plurogen Therapeutics Inc (Inactive)
Queensland University of Technology
Quick-Med Technologies Inc
Quthero Inc
Regentys Corp
Scarless Laboratories Inc
Serina Therapeutics Inc
SolasCure Ltd
Sonoma Pharmaceuticals Inc
Spanish National Research Council
Squid Healthcare Inc
Stanford University
Sunogel Biotechnologies Inc
SynDermix AG
Syracuse Biolabs Inc
Syracuse University
Tectum
Tel Aviv Sourasky Medical Center
Tel Aviv University
Texas Medical Center
Tokyo University of Science
University of California San Diego
University of Florida
University of Illinois at Chicago
University of Pennsylvania
University of Queensland
University of Wisconsin Madison
Ventrix Inc
VTT Technical Research Centre of Finland Ltd
Washington University in St Louis
Zeomedix, LLC

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 8

|1.2 List of Figures 14

2 Introduction 15

2.1 Hydrogels Overview 15

3 Products under Development 16

3.1 Hydrogels – Pipeline Products by Stage of Development 16

3.2 Hydrogels – Pipeline Products by Segment 17

3.3 Hydrogels – Pipeline Products by Territory 18

3.4 Hydrogels – Pipeline Products by Regulatory Path 20

3.5 Hydrogels – Pipeline Products by Estimated Approval Date 21

3.6 Hydrogels – Ongoing Clinical Trials 22

4 Hydrogels – Pipeline Products under Development by Companies 23

4.1 Hydrogels Companies – Pipeline Products by Stage of Development 23

4.2 Hydrogels – Pipeline Products by Stage of Development 26

5 Hydrogels Companies and Product Overview 29

5.1 3QMatrix, Inc. (Inactive) Company Overview 29

5.1.1 3QMatrix, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 29

5.2 Abeona Therapeutics Inc Company Overview 30

5.2.1 Abeona Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 30

5.3 Alafair Biosciences Inc Company Overview 31

5.3.1 Alafair Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 31

5.4 Albert Ludwigs University of Freiburg Company Overview 33

5.4.1 Albert Ludwigs University of Freiburg Pipeline Products & Ongoing Clinical Trials Overview 33

5.5 Amend Surgical, Inc. Company Overview 34

5.5.1 Amend Surgical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 34

5.6 Angiotech Pharmaceuticals Inc Company Overview 35

5.6.1 Angiotech Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 35

5.7 AXXO Im- und Export GmbH Company Overview 36

5.7.1 AXXO Im- und Export GmbH Pipeline Products & Ongoing Clinical Trials Overview 36

5.8 BioCure Inc Company Overview 37

5.8.1 BioCure Inc Pipeline Products & Ongoing Clinical Trials Overview 37

5.9 Biomendics LLC Company Overview 38

5.9.1 Biomendics LLC Pipeline Products & Ongoing Clinical Trials Overview 38

5.10 Brigham and Women’s Hospital Company Overview 41

5.10.1 Brigham and Women’s Hospital Pipeline Products & Ongoing Clinical Trials Overview 41

5.11 CelaCare Technologies LLC Company Overview 42

5.11.1 CelaCare Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 42

5.12 Ceramicos Para Aplicacoes Medicas SA Company Overview 45

5.12.1 Ceramicos Para Aplicacoes Medicas SA Pipeline Products & Ongoing Clinical Trials Overview 45

5.13 Chi2Gel Ltd. Company Overview 46

5.13.1 Chi2Gel Ltd. Pipeline Products & Ongoing Clinical Trials Overview 46

5.14 Clyra Medical Technologies Inc Company Overview 47

5.14.1 Clyra Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 47

5.15 CorMedix Inc Company Overview 48

5.15.1 CorMedix Inc Pipeline Products & Ongoing Clinical Trials Overview 48

5.16 Drexel University Company Overview 50

5.16.1 Drexel University Pipeline Products & Ongoing Clinical Trials Overview 50

5.17 ECM Therapeutics Inc Company Overview 51

5.17.1 ECM Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 51

5.18 Edixomed Ltd Company Overview 52

5.18.1 Edixomed Ltd Pipeline Products & Ongoing Clinical Trials Overview 52

5.19 Exogenus Therapeutics SA Company Overview 57

5.19.1 Exogenus Therapeutics SA Pipeline Products & Ongoing Clinical Trials Overview 57

5.20 Flexion Therapeutics Inc Company Overview 58

5.20.1 Flexion Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 58

5.21 Gel4Med Inc Company Overview 59

5.21.1 Gel4Med Inc Pipeline Products & Ongoing Clinical Trials Overview 59

5.22 Gelesis Inc Company Overview 62

5.22.1 Gelesis Inc Pipeline Products & Ongoing Clinical Trials Overview 62

5.23 GelSana Therapeutics Inc Company Overview 63

5.23.1 GelSana Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 63

5.24 HyperBranch Medical Technology Inc Company Overview 64

5.24.1 HyperBranch Medical Technology Inc Pipeline Products & Ongoing Clinical Trials Overview 64

5.25 Icahn School of Medicine at Mount Sinai Company Overview 65

5.25.1 Icahn School of Medicine at Mount Sinai Pipeline Products & Ongoing Clinical Trials Overview 65

5.26 In2cure AB Company Overview 66

5.26.1 In2cure AB Pipeline Products & Ongoing Clinical Trials Overview 66

5.27 Indian Institute of Technology Delhi Company Overview 67

5.27.1 Indian Institute of Technology Delhi Pipeline Products & Ongoing Clinical Trials Overview 67

5.28 Indian Institute of Technology, Kanpur Company Overview 68

5.28.1 Indian Institute of Technology, Kanpur Pipeline Products & Ongoing Clinical Trials Overview 68

5.29 Institute of Nano Science and Technology Company Overview 69

5.29.1 Institute of Nano Science and Technology Pipeline Products & Ongoing Clinical Trials Overview 69

5.30 Ionic Pharmaceuticals LLC Company Overview 70

5.30.1 Ionic Pharmaceuticals LLC Pipeline Products & Ongoing Clinical Trials Overview 70

5.31 IPI Singapore Company Overview 71

5.31.1 IPI Singapore Pipeline Products & Ongoing Clinical Trials Overview 71

5.32 Jenarron Therapeutics Ltd Company Overview 73

5.32.1 Jenarron Therapeutics Ltd Pipeline Products & Ongoing Clinical Trials Overview 73

5.33 Johns Hopkins University Company Overview 74

5.33.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 74

5.34 Kane Biotech Inc Company Overview 75

5.34.1 Kane Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview 75

5.35 Keratin Biosciences Inc Company Overview 80

5.35.1 Keratin Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 80

5.36 Magle Chemoswed AB Company Overview 81

5.36.1 Magle Chemoswed AB Pipeline Products & Ongoing Clinical Trials Overview 81

5.37 McMaster University Company Overview 82

5.37.1 McMaster University Pipeline Products & Ongoing Clinical Trials Overview 82

5.38 Missouri University of Science and Technology Company Overview 83

5.38.1 Missouri University of Science and Technology Pipeline Products & Ongoing Clinical Trials Overview 83

5.39 Neotherix Ltd Company Overview 84

5.39.1 Neotherix Ltd Pipeline Products & Ongoing Clinical Trials Overview 84

5.40 Northwestern University Company Overview 85

5.40.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 85

5.41 Novyx Technologies LLC Company Overview 89

5.41.1 Novyx Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 89

5.42 O2 Regentech LLC Company Overview 90

5.42.1 O2 Regentech LLC Pipeline Products & Ongoing Clinical Trials Overview 90

5.43 Ohio State University Company Overview 91

5.43.1 Ohio State University Pipeline Products & Ongoing Clinical Trials Overview 91

5.44 Orla Protein Technologies Ltd Company Overview 92

5.44.1 Orla Protein Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 92

5.45 Piramal Enterprises Ltd Company Overview 93

5.45.1 Piramal Enterprises Ltd Pipeline Products & Ongoing Clinical Trials Overview 93

5.46 Plurogen Therapeutics Inc (Inactive) Company Overview 94

5.46.1 Plurogen Therapeutics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 94

5.47 Queensland University of Technology Company Overview 97

5.47.1 Queensland University of Technology Pipeline Products & Ongoing Clinical Trials Overview 97

5.48 Quick-Med Technologies Inc Company Overview 98

5.48.1 Quick-Med Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 98

5.49 Quthero Inc Company Overview 99

5.49.1 Quthero Inc Pipeline Products & Ongoing Clinical Trials Overview 99

5.50 Regentys Corp Company Overview 100

5.50.1 Regentys Corp Pipeline Products & Ongoing Clinical Trials Overview 100

5.51 Scarless Laboratories Inc Company Overview 102

5.51.1 Scarless Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview 102

5.52 Serina Therapeutics Inc Company Overview 103

5.52.1 Serina Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 103

5.53 SolasCure Ltd Company Overview 104

5.53.1 SolasCure Ltd Pipeline Products & Ongoing Clinical Trials Overview 104

5.54 Sonoma Pharmaceuticals Inc Company Overview 105

5.54.1 Sonoma Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 105

5.55 Spanish National Research Council Company Overview 106

5.55.1 Spanish National Research Council Pipeline Products & Ongoing Clinical Trials Overview 106

5.56 Squid Healthcare Inc Company Overview 107

5.56.1 Squid Healthcare Inc Pipeline Products & Ongoing Clinical Trials Overview 107

5.57 Stanford University Company Overview 108

5.57.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview 108

5.58 Sunogel Biotechnologies Inc Company Overview 109

5.58.1 Sunogel Biotechnologies Inc Pipeline Products & Ongoing Clinical Trials Overview 109

5.59 SynDermix AG Company Overview 111

5.59.1 SynDermix AG Pipeline Products & Ongoing Clinical Trials Overview 111

5.60 Syracuse Biolabs Inc Company Overview 112

5.60.1 Syracuse Biolabs Inc Pipeline Products & Ongoing Clinical Trials Overview 112

5.61 Syracuse University Company Overview 113

5.61.1 Syracuse University Pipeline Products & Ongoing Clinical Trials Overview 113

5.62 Tectum Company Overview 115

5.62.1 Tectum Pipeline Products & Ongoing Clinical Trials Overview 115

5.63 Tel Aviv Sourasky Medical Center Company Overview 116

5.63.1 Tel Aviv Sourasky Medical Center Pipeline Products & Ongoing Clinical Trials Overview 116

5.64 Tel Aviv University Company Overview 117

5.64.1 Tel Aviv University Pipeline Products & Ongoing Clinical Trials Overview 117

5.65 Texas Medical Center Company Overview 118

5.65.1 Texas Medical Center Pipeline Products & Ongoing Clinical Trials Overview 118

5.66 Tokyo University of Science Company Overview 119

5.66.1 Tokyo University of Science Pipeline Products & Ongoing Clinical Trials Overview 119

5.67 University of California San Diego Company Overview 120

5.67.1 University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview 120

5.68 University of Florida Company Overview 121

5.68.1 University of Florida Pipeline Products & Ongoing Clinical Trials Overview 121

5.69 University of Illinois at Chicago Company Overview 122

5.69.1 University of Illinois at Chicago Pipeline Products & Ongoing Clinical Trials Overview 122

5.70 University of Pennsylvania Company Overview 123

5.70.1 University of Pennsylvania Pipeline Products & Ongoing Clinical Trials Overview 123

5.71 University of Queensland Company Overview 124

5.71.1 University of Queensland Pipeline Products & Ongoing Clinical Trials Overview 124

5.72 University of Wisconsin Madison Company Overview 125

5.72.1 University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview 125

5.73 Ventrix Inc Company Overview 126

5.73.1 Ventrix Inc Pipeline Products & Ongoing Clinical Trials Overview 126

5.74 VTT Technical Research Centre of Finland Ltd Company Overview 127

5.74.1 VTT Technical Research Centre of Finland Ltd Pipeline Products & Ongoing Clinical Trials Overview 127

5.75 Washington University in St Louis Company Overview 128

5.75.1 Washington University in St Louis Pipeline Products & Ongoing Clinical Trials Overview 128

5.76 Zeomedix, LLC Company Overview 129

5.76.1 Zeomedix, LLC Pipeline Products & Ongoing Clinical Trials Overview 129

6 Hydrogels- Recent Developments 130

6.1 Jun 27, 2024: Kane Biotech Makes First Commercial Sale of Revyve Antimicrobial Wound Gel to Progenacare Global 130

6.2 Jun 25, 2024: ArcticZymes Technologies Announces Nomination of Dr. Frank Mathias as Chairman of the Board 130

6.3 Jun 25, 2024: ArcticZymes Appoints New Chairman – TipRanks.com 131

6.4 Jun 17, 2024: Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2024 Financial Results 131

6.5 Jun 03, 2024: SolasCure Selected for Innovate UK Global Incubator Programme in Houston 132

6.6 May 22, 2024: Covalon Announces Conference Call to Discuss Second Quarter Fiscal 2024 Financial Results 133

6.7 May 10, 2024: Stratus Appoints Selim Benbadis, MD National Medical Director 133

6.8 May 09, 2024: Lineage Cell Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update 134

6.9 May 09, 2024: Collegium Announces CEO Transition 136

6.10 May 08, 2024: ArcticZymes Technologies Q1 2024 Results 136

6.11 May 08, 2024: Piramal Enterprises Q4 Results: Firm posts 137-Crore Net Profit, Declares 10 Dividend 137

6.12 May 07, 2024: Baxter to Present at Bank of America 2024 Health Care Conference 137

6.13 May 06, 2024: NEXGEL to Present at the Aegis Capital Virtual Conference on May 9, 2024 137

6.14 Apr 09, 2024: Publication of Study Showing BLASTX Increases The Efficacy of Negative Pressure Wound Therapy 137

6.15 Apr 02, 2024: Arcticzymes Technologies Announces Resignation of Board Member 138

6.16 Mar 31, 2024: NEXGEL Announces Q4 and Full-Year 2023 Earnings Call Date 138

6.17 Mar 27, 2024: Sonoma Pharmaceuticals Highlights Safety Advantages of its Microcyn Products in Light of Growing Concerns of Benzene in Many Other Topicals 138

6.18 Mar 18, 2024: Abeona Therapeutics Reports Full Year 2023 Financial Results and Announces Completion of FDA Inspections 139

6.19 Mar 04, 2024: SolasCure Publishes Phase IIa Clinical Trial Report in Leading Wound Care Journal 140

6.20 Feb 28, 2024: Covalon to Hold Annual Meeting of Shareholders on Wednesday, March 6, 2024 141

6.21 Feb 12, 2024: Smith+Nephew to Attend AAOS 2024 Annual Meeting 141

6.22 Feb 08, 2024: Baxter Reports Fourth-Quarter and Full-Year 2023 Results 142

6.23 Jan 29, 2024: ArcticZymes Technologies Announces Invitation to Presentation of Q4 2023 Results 145

6.24 Jan 29, 2024: Piramal Enterprises Reports Loss of Rs 2378 Crore in Q3 due to RBI’s Norms 145

6.25 Jan 26, 2024: Covalon Announces Management Changes 145

6.26 Jan 25, 2024: Kane Biotech to Present its revyv Antimicrobial Wound Gel at Boswick Burn and Wound Care Symposium 146

6.27 Jan 18, 2024: NEXGEL to Present at The Microcap Conference, January 30th through February 1st 146

6.28 Jan 04, 2024: Baxter to Host Fourth-Quarter 2023 Financial Results Conference Call for Investors 146

6.29 Jan 04, 2024: Covalon Technologies Announces the Appointment of Experienced MedTech Executive Mr. Brent Ashton as New CEO 147

6.30 Dec 14, 2023: Winner Medical Receives FDA 510(k) Clearance for Antibacterial Gel Wound Dressing 147

6.31 Dec 12, 2023: SolasCure Demonstrates Proof-of-Concept in Phase lla Safety Trial of Aurase Wound Gel 148

6.32 Nov 13, 2023: Nexgel Reports Record Third Quarter 2023 Revenue of $1.2 Million, an Increase of 115% Year-Over-Year 149

6.33 Oct 27, 2023: ArcticZymes Technologies Invitation to Presentation of Q3 2023 Results 150

6.34 Oct 25, 2023: Kane Biotech to Exhibit at Symposium on Advanced Wound Care Fall Forum 150

6.35 Oct 19, 2023: Piramal Enterprises to Raise Up to Rs 1,000 Crore 150

6.36 Oct 03, 2023: Baxter Appoints Joel Grade Chief Financial Officer 150

6.37 Oct 02, 2023: Advanced Medical Solutions Group Announces Appointment of New Chair 151

6.38 Sep 19, 2023: Baxter to Host Third-Quarter 2023 Financial Results Conference Call for Investors 152

6.39 Sep 14, 2023: Smith & Nephew Brings BT Chief Financial Officer Simon Lowth to Board 152

6.40 Sep 14, 2023: New Non Executive Directors Join the Board at Med Tech Business 152

6.41 Sep 14, 2023: Smith & Nephew Announces Board Changes 152

6.42 Aug 15, 2023: Convatec Group Appoints Robyn Butler-Mason as Company Secretary 153

6.43 Aug 14, 2023: ArcticZymes Technologies Announces Invitation to Presentation of Q2 2023 Results 153

6.44 Aug 14, 2023: NEXGEL Reports Second Quarter 2023 Record Revenue of $1.17 Million, an Increase of 108% Year-Over-Year 154

6.45 Aug 10, 2023: Advanced Medical Solutions Group Notice of Interim Results 155

6.46 Aug 03, 2023: Collegium Reports Record 1H’23 Net Revenue of $280.3 Million, Up 35% Year-over-Year 155

6.47 Aug 02, 2023: ConvaTec Group Announces Interim Results for the six months ended 30 June 2023 156

6.48 Aug 01, 2023: S&T Researchers Developing New Dressings for Better Wound Care 157

6.49 Aug 01, 2023: S&T Researchers Developing New Dressings for Better Wound Care 158

7 Appendix 159

7.1 Methodology 159

7.2 About GlobalData 162

7.3 Contact Us 162

7.4 Disclaimer 162

Table

Hydrogels – Pipeline Products by Stage of Development 16

Hydrogels – Pipeline Products by Segment 17

Hydrogels – Pipeline Products by Territory 18

Hydrogels – Pipeline Products by Regulatory Path 20

Hydrogels – Pipeline Products by Estimated Approval Date 21

Hydrogels – Ongoing Clinical Trials 22

Hydrogels Companies – Pipeline Products by Stage of Development 23

Hydrogels – Pipeline Products by Stage of Development 26

3QMatrix, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 29

Bi-layer Dressing – Product Status 29

Bi-layer Dressing – Product Description 29

Abeona Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 30

BenzaGard – Product Status 30

BenzaGard – Product Description 30

Alafair Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 31

Alafair Bilayer – Product Status 31

Alafair Bilayer – Product Description 31

Alafair Injectable Gel – Product Status 32

Alafair Injectable Gel – Product Description 32

Albert Ludwigs University of Freiburg Pipeline Products & Ongoing Clinical Trials Overview 33

PEG-Hydrogel – Product Status 33

PEG-Hydrogel – Product Description 33

Amend Surgical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 34

Oral Hydrogel Adhesive – Product Status 34

Oral Hydrogel Adhesive – Product Description 34

Angiotech Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 35

Adhibit – Product Status 35

Adhibit – Product Description 35

AXXO Im- und Export GmbH Pipeline Products & Ongoing Clinical Trials Overview 36

AXXO Woundgel – Product Status 36

AXXO Woundgel – Product Description 36

BioCure Inc Pipeline Products & Ongoing Clinical Trials Overview 37

Growth Factor Delivery – Hydrogel Wound Dressing – Product Status 37

Growth Factor Delivery – Hydrogel Wound Dressing – Product Description 37

Biomendics LLC Pipeline Products & Ongoing Clinical Trials Overview 38

TolaSure Topical Gel – Acute Wounds – Product Status 38

TolaSure Topical Gel – Acute Wounds – Product Description 38

Tolasure Topical Gel – Burns – Product Status 39

Tolasure Topical Gel – Burns – Product Description 39

Tolasure Topical Gel – Chronic Wounds – Product Status 39

Tolasure Topical Gel – Chronic Wounds – Product Description 40

Tolasure Topical Gel – Skin Ulcers – Product Status 40

Tolasure Topical Gel – Skin Ulcers – Product Description 40

Brigham and Women’s Hospital Pipeline Products & Ongoing Clinical Trials Overview 41

ELP Hydrogel – Product Status 41

ELP Hydrogel – Product Description 41

CelaCare Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 42

OTC Antimicrobial Gel – Product Status 42

OTC Antimicrobial Gel – Product Description 42

Prescription Gel 1 – Product Status 43

Prescription Gel 1 – Product Description 43

Prescription Gel 2 – Product Status 43

Prescription Gel 2 – Product Description 44

Ceramicos Para Aplicacoes Medicas SA Pipeline Products & Ongoing Clinical Trials Overview 45

HidroKi – Product Status 45

HidroKi – Product Description 45

Chi2Gel Ltd. Pipeline Products & Ongoing Clinical Trials Overview 46

Chi2Gel Wound Dressing – Product Status 46

Chi2Gel Wound Dressing – Product Description 46

Clyra Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 47

Wound Gel – Product Status 47

Wound Gel – Product Description 47

CorMedix Inc Pipeline Products & Ongoing Clinical Trials Overview 48

CMDX-007 – Topical Hydrogel – Product Status 48

CMDX-007 – Topical Hydrogel – Product Description 48

CRMD-009 – Nanoparticle Hydrogel – Product Status 49

CRMD-009 – Nanoparticle Hydrogel – Product Description 49

Drexel University Pipeline Products & Ongoing Clinical Trials Overview 50

Immunomodulatory Hydrogel Dressing – Product Status 50

Immunomodulatory Hydrogel Dressing – Product Description 50

ECM Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 51

ECM Hydrogel – Anorectal Fistula Repair – Product Status 51

ECM Hydrogel – Anorectal Fistula Repair – Product Description 51

Edixomed Ltd Pipeline Products & Ongoing Clinical Trials Overview 52

EDX110 – Burns – Product Status 52

EDX110 – Burns – Product Description 52

EDX110 – Cystic Fibrosis – Product Status 53

EDX110 – Cystic Fibrosis – Product Description 53

EDX110 – Diabetic Foot Ulcer – Product Status 53

EDX110 – Diabetic Foot Ulcer – Product Description 54

EDX110 – Pressure Ulcers – Product Status 54

EDX110 – Pressure Ulcers – Product Description 54

EDX110 – Septic Shock – Product Status 55

EDX110 – Septic Shock – Product Description 55

EDX110 – Surgical Wounds – Product Status 55

EDX110 – Surgical Wounds – Product Description 56

EDX110 – Venous Leg Ulcers – Product Status 56

EDX110 – Venous Leg Ulcers – Product Description 56

Exogenus Therapeutics SA Pipeline Products & Ongoing Clinical Trials Overview 57

Exo-Wound – Product Status 57

Exo-Wound – Product Description 57

Flexion Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 58

FX301 – Product Status 58

FX301 – Product Description 58

Gel4Med Inc Pipeline Products & Ongoing Clinical Trials Overview 59

G4db – Product Status 59

G4db – Product Description 59

G4I – Product Status 60

G4I – Product Description 60

G4Surg – Product Status 60

G4Surg – Product Description 61

Gelesis Inc Pipeline Products & Ongoing Clinical Trials Overview 62

Gel-B – Product Status 62

Gel-B – Product Description 62

GelSana Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 63

Cleragel – Product Status 63

Cleragel – Product Description 63

HyperBranch Medical Technology Inc Pipeline Products & Ongoing Clinical Trials Overview 64

Adherus MIS – Product Status 64

Adherus MIS – Product Description 64

Icahn School of Medicine at Mount Sinai Pipeline Products & Ongoing Clinical Trials Overview 65

FibGen – Product Status 65

FibGen – Product Description 65

In2cure AB Pipeline Products & Ongoing Clinical Trials Overview 66

TCP-25 – Product Status 66

TCP-25 – Product Description 66

Indian Institute of Technology Delhi Pipeline Products & Ongoing Clinical Trials Overview 67

Layered Hydrogel Scaffold – Product Status 67

Layered Hydrogel Scaffold – Product Description 67

Indian Institute of Technology, Kanpur Pipeline Products & Ongoing Clinical Trials Overview 68

Hydrogel Dressing – Chronic Wounds And Infection – Product Status 68

Hydrogel Dressing – Chronic Wounds And Infection – Product Description 68

Institute of Nano Science and Technology Pipeline Products & Ongoing Clinical Trials Overview 69

Smart Injectable Hydrogel – Product Status 69

Smart Injectable Hydrogel – Product Description 69

Ionic Pharmaceuticals LLC Pipeline Products & Ongoing Clinical Trials Overview 70

HydrAid Burn Dressing – Product Status 70

HydrAid Burn Dressing – Product Description 70

IPI Singapore Pipeline Products & Ongoing Clinical Trials Overview 71

Hyaluronic Acid-Based Gel – Product Status 71

Hyaluronic Acid-Based Gel – Product Description 71

Keratin Hydrogel – Product Status 71

Keratin Hydrogel – Product Description 72

Jenarron Therapeutics Ltd Pipeline Products & Ongoing Clinical Trials Overview 73

JA01 Lidocaine Rheo-Gel – Product Status 73

JA01 Lidocaine Rheo-Gel – Product Description 73

Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 74

Chondroitin Sulfate Hydrogel – Product Status 74

Chondroitin Sulfate Hydrogel – Product Description 74

Kane Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview 75

DispersinB Hydrogel – Product Status 75

DispersinB Hydrogel – Product Description 76

DispersinB Hydrogel – Prosthetic Joint Infection – Product Status 76

DispersinB Hydrogel – Prosthetic Joint Infection – Product Description 76

revyve Antimicrobial Wound Gel Spray – Product Status 77

revyve Antimicrobial Wound Gel Spray – Product Description 77

Kane Biotech Inc – Ongoing Clinical Trials Overview 78

DispersinB Hydrogel – A Study to Evaluate the Safety of DispersinB Hydrogel 79

Keratin Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 80

Keratin-Based Hydrogel Wound Dressing – Product Status 80

Keratin-Based Hydrogel Wound Dressing – Product Description 80

Magle Chemoswed AB Pipeline Products & Ongoing Clinical Trials Overview 81

SmartGel II – Product Status 81

SmartGel II – Product Description 81

McMaster University Pipeline Products & Ongoing Clinical Trials Overview 82

Antibacterial Phage Hydrogel – Product Status 82

Antibacterial Phage Hydrogel – Product Description 82

Missouri University of Science and Technology Pipeline Products & Ongoing Clinical Trials Overview 83

3D-Printed Hydrogel Dressing – Product Status 83

3D-Printed Hydrogel Dressing – Product Description 83

Neotherix Ltd Pipeline Products & Ongoing Clinical Trials Overview 84

RegeniTherix – Product Status 84

RegeniTherix – Product Description 84

Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 85

Biocompatible Hydrogel – Product Status 85

Biocompatible Hydrogel – Product Description 85

Copper Based Hydrogel Wound Dressing – Product Status 86

Copper Based Hydrogel Wound Dressing – Product Description 86

pH Responsive Self-Healing Hydrogel – Product Status 86

pH Responsive Self-Healing Hydrogel – Product Description 87

Thermoresponsive Cell Adhesive Bioresorbable Dressing – Product Status 87

Thermoresponsive Cell Adhesive Bioresorbable Dressing – Product Description 87

Tissue Sealant – Fetal Membrane Repair – Product Status 88

Tissue Sealant – Fetal Membrane Repair – Product Description 88

Novyx Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 89

Hydrogel Wound Dressing – Product Status 89

Hydrogel Wound Dressing – Product Description 89

O2 Regentech LLC Pipeline Products & Ongoing Clinical Trials Overview 90

OXAID – Product Status 90

OXAID – Product Description 90

Ohio State University Pipeline Products & Ongoing Clinical Trials Overview 91

MG53 Hydrogel – Product Status 91

MG53 Hydrogel – Product Description 91

Orla Protein Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 92

Synthetic ECM Hydrogel – Product Status 92

Synthetic ECM Hydrogel – Product Description 92

Piramal Enterprises Ltd Pipeline Products & Ongoing Clinical Trials Overview 93

BST-DermOn – Product Status 93

BST-DermOn – Product Description 93

Plurogen Therapeutics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 94

PluroGel PNN – Product Status 94

PluroGel PNN – Product Description 94

Plurogen Therapeutics Inc (Inactive) – Ongoing Clinical Trials Overview 95

PluroGel PNN – A Between Patient, Pilot Randomized Controlled Study of Plurogel Compared to Standard Topical Dressing in Burn Injuries 96

PluroGel PNN – A Within Patient, Pilot Randomized Controlled Study of Plurogel Compared to Standard Topical Dressing in Burn Injuries 96

Queensland University of Technology Pipeline Products & Ongoing Clinical Trials Overview 97

Antibiotic Hydrogel – Product Status 97

Antibiotic Hydrogel – Product Description 97

Quick-Med Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 98

Nimbus Hydrogel – Product Status 98

Nimbus Hydrogel – Product Description 98

Quthero Inc Pipeline Products & Ongoing Clinical Trials Overview 99

Q-gel – Product Status 99

Q-gel – Product Description 99

Regentys Corp Pipeline Products & Ongoing Clinical Trials Overview 100

ECMH (Extracellular Matrix Hydrogel) – Crohn’s Disease – Product Status 100

ECMH (Extracellular Matrix Hydrogel) – Crohn’s Disease – Product Description 100

ECMH Rectal Solution – Ulcerative Colitis – Product Status 101

ECMH Rectal Solution – Ulcerative Colitis – Product Description 101

Scarless Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview 102

HA-SLI-F06 Hydrogel – Product Status 102

HA-SLI-F06 Hydrogel – Product Description 102

Serina Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 103

Renelon – Product Status 103

Renelon – Product Description 103

SolasCure Ltd Pipeline Products & Ongoing Clinical Trials Overview 104

Aurase – Product Status 104

Aurase – Product Description 104

Sonoma Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 105

Microcyn Allergen Shield Hydrogel – Product Status 105

Microcyn Allergen Shield Hydrogel – Product Description 105

Spanish National Research Council Pipeline Products & Ongoing Clinical Trials Overview 106

Multicomponent Hydrogel – Product Status 106

Multicomponent Hydrogel – Product Description 106

Squid Healthcare Inc Pipeline Products & Ongoing Clinical Trials Overview 107

EyeMask MD – Product Status 107

EyeMask MD – Product Description 107

Stanford University Pipeline Products & Ongoing Clinical Trials Overview 108

Gel-Aid – Product Status 108

Gel-Aid – Product Description 108

Sunogel Biotechnologies Inc Pipeline Products & Ongoing Clinical Trials Overview 109

WizGel-DX1 – Product Status 109

WizGel-DX1 – Product Description 109

WizGel-DX2 – Product Status 110

WizGel-DX2 – Product Description 110

SynDermix AG Pipeline Products & Ongoing Clinical Trials Overview 111

PGX-10 – Product Status 111

PGX-10 – Product Description 111

Syracuse Biolabs Inc Pipeline Products & Ongoing Clinical Trials Overview 112

Hydrogel – Anti-Infection Wound Care Dressing – Product Status 112

Hydrogel – Anti-Infection Wound Care Dressing – Product Description 112

Syracuse University Pipeline Products & Ongoing Clinical Trials Overview 113

Antimicrobial Hydrogel Web – Product Status 113

Antimicrobial Hydrogel Web – Product Description 113

Shape Memory Polymer Hydrogel – Product Status 114

Shape Memory Polymer Hydrogel – Product Description 114

Tectum Pipeline Products & Ongoing Clinical Trials Overview 115

Wound Healing Gel – Product Status 115

Wound Healing Gel – Product Description 115

Tel Aviv Sourasky Medical Center Pipeline Products & Ongoing Clinical Trials Overview 116

Guided Regeneration Gel – Product Status 116

Guided Regeneration Gel – Product Description 116

Tel Aviv University Pipeline Products & Ongoing Clinical Trials Overview 117

Self Assembled Peptide Hydrogel (SAPH) – Product Status 117

Self Assembled Peptide Hydrogel (SAPH) – Product Description 117

Texas Medical Center Pipeline Products & Ongoing Clinical Trials Overview 118

Extracellular Matrix Hydrogel Spray – Product Status 118

Extracellular Matrix Hydrogel Spray – Product Description 118

Tokyo University of Science Pipeline Products & Ongoing Clinical Trials Overview 119

Alkaline Hydrogel – Product Status 119

Alkaline Hydrogel – Product Description 119

University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview 120

Self Healing Hydrogel – Product Status 120

Self Healing Hydrogel – Product Description 120

University of Florida Pipeline Products & Ongoing Clinical Trials Overview 121

Hydrogel Device – Product Status 121

Hydrogel Device – Product Description 121

University of Illinois at Chicago Pipeline Products & Ongoing Clinical Trials Overview 122

Hydrogel – Wound Healing – Product Status 122

Hydrogel – Wound Healing – Product Description 122

University of Pennsylvania Pipeline Products & Ongoing Clinical Trials Overview 123

Self-Healing Hydrogel – Product Status 123

Self-Healing Hydrogel – Product Description 123

University of Queensland Pipeline Products & Ongoing Clinical Trials Overview 124

Peptide Hydrogel – Product Status 124

Peptide Hydrogel – Product Description 124

University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview 125

Hydrogel Microspheres – Product Status 125

Hydrogel Microspheres – Product Description 125

Ventrix Inc Pipeline Products & Ongoing Clinical Trials Overview 126

VentriGel – Product Status 126

VentriGel – Product Description 126

VTT Technical Research Centre of Finland Ltd Pipeline Products & Ongoing Clinical Trials Overview 127

3D Nanocellulose Hydrogel Device – Product Status 127

3D Nanocellulose Hydrogel Device – Product Description 127

Washington University in St Louis Pipeline Products & Ongoing Clinical Trials Overview 128

Oxygen-Releasing Hydrogel – Product Status 128

Oxygen-Releasing Hydrogel – Product Description 128

Zeomedix, LLC Pipeline Products & Ongoing Clinical Trials Overview 129

Zeomedix Hydrogel – Product Status 129

Zeomedix Hydrogel – Product Description 129

Glossary 161

Figures

Hydrogels – Pipeline Products by Stage of Development 16

Hydrogels – Pipeline Products by Segment 17

Hydrogels – Pipeline Products by Territory 18

Hydrogels – Pipeline Products by Regulatory Path 20

Hydrogels – Pipeline Products by Estimated Approval Date 21

Hydrogels – Ongoing Clinical Trials 22

Frequently asked questions

Hydrogels Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies standard reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

Hydrogels Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Hydrogels Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies in real time.

  • Access a live Hydrogels Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.